Uvax Bio plans $8M expansion in Glasgow
GLASGOW -- Uvax Bio, an early-stage vaccine technology company, is planning an $8 million expansion of its research and production work in Delaware, building out a lab and hiring d…
GLASGOW -- Uvax Bio, an early-stage vaccine technology company, is planning an $8 million expansion of its research and production work in Delaware, building out a lab and hiring d…